Shaodong Hong
Clinical trials sponsored by Shaodong Hong, explained in plain language.
-
Two-Drug combo targets Hard-to-Treat recurrent small cell lung cancer
Disease control Not yet recruitingResearchers are testing a combination of paclitaxel polymeric micelles and ivonescimab in adults with small cell lung cancer that has returned or stopped responding after platinum-based chemotherapy and anti-PD-1/PD-L1 therapy. The phase 2 trial aims to see how many participants'…
Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
Two-Drug combo aims to shrink lung tumors before surgery
Disease control Not yet recruitingResearchers are testing whether giving toripalimab plus sacituzumab tirumotecan before surgery helps people with resectable non-small cell lung cancer. The trial enrolls about 30 adults with stage II to IIIB disease that has not been treated and lacks certain driver mutations. Pa…
Phase 2 • Sponsor: Shaodong Hong • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC